Research and Application of Chitosan Nanoparticles in Orthopedic Infections

References

• Masters EA, Ricciardi BF, Bentley KL, et al. Skeletal infections: microbial pathogenesis, immunity, and clinical management. Nat Rev Microbiol. 2022;20(7):385–400. doi:10.1038/s41579-022-00686-0
   PubMed Web of Science ®Google Scholar
• Pincher B, Fenton C, Jeyapalan R, et al. A systematic review of the single-stage treatment of chronic osteomyelitis. J Orthop Surg Res. 2019;14(1):393. doi:10.1186/s13018-019-1388-2
   PubMed Web of Science ®Google Scholar
• Hoskins W, Rainbird S, Peng Y, et al. Incidence, Risk Factors, and Outcome of Ceramic-On-Ceramic Bearing Breakage in Total Hip Arthroplasty. J Arthroplasty. 2021;36(8):2992–2997. doi:10.1016/j.arth.2021.03.021
   PubMed Web of Science ®Google Scholar
• D’Amore T, Goh GS, Courtney PM, et al. Hospital Charges Are Not Associated With Episode-of-Care Costs or Complications After Total Joint Arthroplasty. J Arthroplasty. 2022;37(8S):S727–S731. doi:10.1016/j.arth.2022.01.018
   PubMedGoogle Scholar
• Patel R. Periprosthetic Joint Infection. N Engl J Med. 2023;388(3):251–262. doi:10.1056/NEJMra2203477
   PubMed Web of Science ®Google Scholar
• Li S, Meng Y, Pan J, et al. Novel, static, permanent spacers to treat chronic knee periprosthetic joint infections. Int Orthop. 2023;47(10):2585–2589. doi:10.1007/s00264-023-05884-w
   PubMed Web of Science ®Google Scholar
• Senneville E, Dinh A, Ferry T, et al. Tolerance of Prolonged Oral Tedizolid for Prosthetic Joint Infections: results of a Multicentre Prospective Study. Antibiotics. 2020;10(1):4. doi:10.3390/antibiotics10010004
   Google Scholar
• Basile G, Gallina M, Passeri A, et al. Prosthetic joint infections and legal disputes: a threat to the future of prosthetic orthopedics. J Orthop Traumatol. 2021;22(1):44. doi:10.1186/s10195-021-00607-6
   PubMed Web of Science ®Google Scholar
• Roof MA, Aggarwal VK, Schwarzkopf R. The Economics of Revision Arthroplasty for Periprosthetic Joint Infection. Arthroplast Today. 2023;23:101213. doi:10.1016/j.artd.2023.101213
   PubMedGoogle Scholar
• Negut I, Ristoscu C, Tozar T, et al. Implant Surfaces Containing Bioglasses and Ciprofloxacin as Platforms for Bone Repair and Improved Resistance to Microbial Colonization. Pharmaceutics. 2022;14(6):1175. doi:10.3390/pharmaceutics14061175
   PubMed Web of Science ®Google Scholar
• Ferreira PG, Ferreira VF, da Silva FDC, et al. Chitosans and Nanochitosans: recent Advances in Skin Protection, Regeneration, and Repair. Pharmaceutics. 2022;14(6):1307. doi:10.3390/pharmaceutics14061307
   PubMed Web of Science ®Google Scholar
• Kankariya Y, Chatterjee B. Biomedical Application of Chitosan and Chitosan Derivatives: a Comprehensive Review. Curr Pharm Des. 2023;29(17):1311–1325. doi:10.2174/1381612829666230524153002
   PubMed Web of Science ®Google Scholar
• Lee JH, Tachibana T, Wadamori H, et al. Drug-Loaded Biocompatible Chitosan Polymeric Films with Both Stretchability and Controlled Release for Drug Delivery. ACS Omega. 2023;8(1):1282–1290. doi:10.1021/acsomega.2c06719
   PubMed Web of Science ®Google Scholar
• Mu H, et al. Chitosan conjugation enables intracellular bacteria susceptible to aminoglycoside antibiotic. Glycobiology. 2016;26(11):1190–1197.
   PubMed Web of Science ®Google Scholar
• Seaberg J, Montazerian H, Hossen MN, et al. Hybrid Nanosystems for Biomedical Applications. ACS Nano. 2021;15(2):2099–2142. doi:10.1021/acsnano.0c09382
   PubMed Web of Science ®Google Scholar
• Fornaguera C, Garcia-Celma MJ. Personalized Nanomedicine: a Revolution at the Nanoscale. J Pers Med. 2017;7(4):12. doi:10.3390/jpm7040012
   PubMed Web of Science ®Google Scholar
• Jha R, Mayanovic RA. A Review of the Preparation, Characterization, and Applications of Chitosan Nanoparticles in Nanomedicine. Nanomaterials (Basel). 2023;13(8):1302. doi:10.3390/nano13081302
   PubMedGoogle Scholar
• Chen YT, Ricciardi BF, Bentley KL, et al. Immunometabolic Regulation of Bacterial Infection, Biofilms, and Antibiotic Susceptibility. J Innate Immun. 2024;16(1):143–158.
   PubMed Web of Science ®Google Scholar
• Snoddy B, Jayasuriya AC. The use of nanomaterials to treat bone infections. Mater Sci Eng C Mater Biol Appl. 2016;67:822–833. doi:10.1016/j.msec.2016.04.062
   PubMed Web of Science ®Google Scholar
• Lu Y, Cai W-J, Ren Z, et al. The Role of Staphylococcal Biofilm on the Surface of Implants in Orthopedic Infection. Microorganisms. 2022;10(10):1909. doi:10.3390/microorganisms10101909
   PubMed Web of Science ®Google Scholar
• Anagnostakos K, Fink B. Antibiotics in Orthopedic Infections. Antibiotics (Basel). 2021;10(11).
   Web of Science ®Google Scholar
• Guo Y, Song G, Sun M, et al. Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus. Front Cell Infect Microbiol. 2020;10:107. doi:10.3389/fcimb.2020.00107
   PubMed Web of Science ®Google Scholar
• Nasser A, Azimi T, Ostadmohammadi S, et al. A comprehensive review of bacterial osteomyelitis with emphasis on Staphylococcus aureus. Microb Pathog. 2020;148:104431. doi:10.1016/j.micpath.2020.104431
   PubMed Web of Science ®Google Scholar
• Mlynarczyk-Bonikowska B, Kowalewski C, Krolak-Ulinska A, et al. Molecular Mechanisms of Drug Resistance in Staphylococcus aureus. Int J Mol Sci. 2022;23(15):8088. doi:10.3390/ijms23158088
   PubMed Web of Science ®Google Scholar
• Mirzaei R, Campoccia D, Ravaioli S, et al. Emerging Issues and Initial Insights into Bacterial Biofilms: from Orthopedic Infection to Metabolomics. Antibiotics (Basel). 2024;13(2):184.
   PubMed Web of Science ®Google Scholar
• Aransiola SA, Selvaraj B, Maddela NR. Bacterial biofilm formation and anti-biofilm strategies. Res Microbiol. 2023;104172.
   PubMed Web of Science ®Google Scholar
• Uruen C, et al. Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance. Antibiotics (Basel). 2020;10(1).
   PubMed Web of Science ®Google Scholar
• Hathroubi S, Mekni MA, Domenico P, et al. Biofilms: microbial Shelters Against Antibiotics. Microb Drug Resist. 2017;23(2):147–156. doi:10.1089/mdr.2016.0087
   PubMed Web of Science ®Google Scholar
• Gebreyohannes G, et al. Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms. Heliyon. 2019;5(8):e02192.
   PubMed Web of Science ®Google Scholar
• Penesyan A, Nagy SS, Kjelleberg S, et al. Rapid microevolution of biofilm cells in response to antibiotics. NPJ Biofilms Microbiomes. 2019;5(1):34. doi:10.1038/s41522-019-0108-3
   PubMedGoogle Scholar
• Zhang K, et al. Promising Therapeutic Strategies Against Microbial Biofilm Challenges. Front Cell Infect Microbiol. 2020;10:359.
   PubMed Web of Science ®Google Scholar
• Gomes P, Forrester M, Pace M, et al. May the force be with you: the role of hyper-mechanostability of the bone sialoprotein binding protein during early stages of Staphylococci infections. Front Chem. 2023;11:1107427. doi:10.3389/fchem.2023.1107427
   PubMed Web of Science ®Google Scholar
• Khalid M, Bora T, Ghaithi AA, et al. Raman Spectroscopy detects changes in Bone Mineral Quality and Collagen Cross-linkage in Staphylococcus Infected Human Bone. Sci Rep. 2018;8(1):9417. doi:10.1038/s41598-018-27752-z
   PubMedGoogle Scholar
• Walter N, Mendelsohn D, Brochhausen C, et al. Intracellular S. aureus in Osteoblasts in a Clinical Sample from a Patient with Chronic Osteomyelitis-A Case Report. Pathogens. 2021;10(8):1064. doi:10.3390/pathogens10081064
   PubMed Web of Science ®Google Scholar
• Peyrusson F, Varet H, Nguyen TK, et al. Intracellular Staphylococcus aureus persisters upon antibiotic exposure. Nat Commun. 2020;11(1):2200. doi:10.1038/s41467-020-15966-7
   PubMed Web of Science ®Google Scholar
• Krauss JL, Roper PM, Ballard A, et al. Staphylococcus aureus Infects Osteoclasts and Replicates Intracellularly. mBio. 2019;10(5). doi:10.1128/mBio.02447-19
   PubMed Web of Science ®Google Scholar
• Proctor R. Respiration and Small Colony Variants of Staphylococcus aureus. Microbiol Spectr. 2019;7(3). doi:10.1128/microbiolspec.GPP3-0069-2019
   Web of Science ®Google Scholar
• Bogut A, Koper P, Marczak M, et al. The first genomic characterization of a stable, hemin-dependent small colony variant strain of Staphylococcus epidermidis isolated from a prosthetic-joint infection. Front Microbiol. 2023;14:1289844. doi:10.3389/fmicb.2023.1289844
   PubMed Web of Science ®Google Scholar
• Zhou S, Rao Y, Li J, et al. Staphylococcus aureus small-colony variants: formation, infection, and treatment. Microbiol Res. 2022;260:127040. doi:10.1016/j.micres.2022.127040
   PubMedGoogle Scholar
• Sato T, Uno T, Kawamura M, et al. In vitro Tolerability of Biofilm-Forming Trimethoprim-/Sulfamethoxazole-Resistant Small Colony Variants of Staphylococcus aureus Against Various Antimicrobial Agents. Microb Drug Resist. 2021;27(9):1282–1289. doi:10.1089/mdr.2020.0379
   PubMed Web of Science ®Google Scholar
• Guo H, et al. Biofilm and Small Colony Variants-An Update on Staphylococcus aureus Strategies toward Drug Resistance. Int J Mol Sci. 2022;23(3):567.
   PubMed Web of Science ®Google Scholar
• Kriegeskorte A, Grubmã¼ller S, Huber C, et al. Staphylococcus aureus small colony variants show common metabolic features in central metabolism irrespective of the underlying auxotrophism. Front Cell Infect Microbiol. 2014;4:141. doi:10.3389/fcimb.2014.00141
   PubMed Web of Science ®Google Scholar
• Pal K, Bharti D, Sarkar P, et al. Selected Applications of Chitosan Composites. Int J Mol Sci. 2021;22(20):10968. doi:10.3390/ijms222010968
   PubMed Web of Science ®Google Scholar
• Shariatinia Z. Carboxymethyl chitosan: properties and biomedical applications. Int J Biol Macromol. 2018;120(Pt B):1406–1419. doi:10.1016/j.ijbiomac.2018.09.131
   PubMed Web of Science ®Google Scholar
• Wang W, Xue C, Mao X. Chitosan: structural modification, biological activity and application. Int J Biol Macromol. 2020;164:4532–4546. doi:10.1016/j.ijbiomac.2020.09.042
   PubMed Web of Science ®Google Scholar
• Lima R, Fernandes C, Pinto MMM. Molecular modifications, biological activities, and applications of chitosan and derivatives: a recent update. Chirality. 2022;34(9):1166–1190. doi:10.1002/chir.23477
   PubMed Web of Science ®Google Scholar
• Ardean C, Davidescu CM, Nemeş NS, et al. Antimicrobial Activities of Chitosan Derivatives. Pharmaceutics. 2021;13(10):1639. doi:10.3390/pharmaceutics13101639
   PubMed Web of Science ®Google Scholar
• Ardean C, Davidescu CM, Nemeş NS, et al. Factors Influencing the Antibacterial Activity of Chitosan and Chitosan Modified by Functionalization. Int J Mol Sci. 2021;22(14):7449. doi:10.3390/ijms22147449
   PubMed Web of Science ®Google Scholar
• Hosseinnejad M, Jafari SM. Evaluation of different factors affecting antimicrobial properties of chitosan. Int J Biol Macromol. 2016;85:467–475. doi:10.1016/j.ijbiomac.2016.01.022
   PubMed Web of Science ®Google Scholar
• Tian Y, Wu D, Wu D, et al. Chitosan-Based Biomaterial Scaffolds for the Repair of Infected Bone Defects. Front Bioeng Biotechnol. 2022;10:899760. doi:10.3389/fbioe.2022.899760
   PubMed Web of Science ®Google Scholar
• Webber JL, Namivandi-Zangeneh R, Drozdek S, et al. Incorporation and antimicrobial activity of nisin Z within carrageenan/chitosan multilayers. Sci Rep. 2021;11(1):1690. doi:10.1038/s41598-020-79702-3
   PubMed Web of Science ®Google Scholar
• Ke CL, Deng F-S, Chuang C-Y, et al. Antimicrobial Actions and Applications of Chitosan. Polymers. 2021;13(6):904. doi:10.3390/polym13060904
   PubMed Web of Science ®Google Scholar
• Perinelli DR, Fagioli L, Campana R, et al. Chitosan-based nanosystems and their exploited antimicrobial activity. Eur J Pharm Sci. 2018;117:8–20. doi:10.1016/j.ejps.2018.01.046
   PubMed Web of Science ®Google Scholar
• Beck BH, Yildirim‐Aksoy M, Shoemaker CA, et al. Antimicrobial activity of the biopolymer chitosan against Streptococcus iniae. J Fish Dis. 2019;42(3):371–377. doi:10.1111/jfd.12938
   PubMed Web of Science ®Google Scholar
• Wang M, Bi S, Qin D, et al. Quantitative evaluation of the antibacterial effectiveness and efficiency of chitosan considering the effect of neutralization. Carbohydr Polym. 2021;265:117918. doi:10.1016/j.carbpol.2021.117918
   PubMed Web of Science ®Google Scholar
• Pelegrino MT, Pieretti JC, Nakazato G, et al. Chitosan chemically modified to deliver nitric oxide with high antibacterial activity. Nitric Oxide. 2021;106:24–34. doi:10.1016/j.niox.2020.10.003
   PubMed Web of Science ®Google Scholar
• Wang L, Xin M, Li M, et al. Effect of the structure of chitosan quaternary phosphonium salt and chitosan quaternary ammonium salt on the antibacterial and antibiofilm activity. Int J Biol Macromol. 2023;242(Pt 2):124877. doi:10.1016/j.ijbiomac.2023.124877
   PubMedGoogle Scholar
• Jonassen H, Kjoniksen A-L, Hiorth M. Stability of chitosan nanoparticles cross-linked with tripolyphosphate. Biomacromolecules. 2012;13(11):3747–3756. doi:10.1021/bm301207a
   PubMed Web of Science ®Google Scholar
• Chae K-S, Shin C-S, Shin W-S. Characteristics of cricket (Gryllus bimaculatus) chitosan and chitosan-based nanoparticles. Food Sci Biotechnol. 2018;27(3):631–639. doi:10.1007/s10068-018-0314-4
   PubMed Web of Science ®Google Scholar
• Ganesan S, Alagarasan JK, Sonaimuthu M, et al. Preparation and Characterization of Salsalate-Loaded Chitosan Nanoparticles: in Vitro Release and Antibacterial and Antibiofilm Activity. Mar Drugs. 2022;20(12):733. doi:10.3390/md20120733
   PubMed Web of Science ®Google Scholar
• Holmes MD, Narro AJ, Jones HL, et al. The potential of suspended chitosan nanoparticles as a surgical irrigation fluid. J Orthop Res. 2024;42(1):223–229. doi:10.1002/jor.25667
   PubMed Web of Science ®Google Scholar
• Dai X, Liu X, Li Y, et al. Nitrogen-phosphorous co-doped carbonized chitosan nanoparticles for chemotherapy and ROS-mediated immunotherapy of intracellular Staphylococcus aureus infection. Carbohydr Polym. 2023;315:121013. doi:10.1016/j.carbpol.2023.121013
   PubMed Web of Science ®Google Scholar
• Haji Hossein Tabrizi A, Habibi M, Foroohi F, et al. Investigation of the effects of antimicrobial and anti-biofilm peptide IDR1018 and chitosan nanoparticles on ciprofloxacin-resistant Escherichia coli. J Basic Microbiol. 2022;62(10):1229–1240. doi:10.1002/jobm.202200156
   PubMed Web of Science ®Google Scholar
• Rivera Aguayo P, Bruna Larenas T, Alarcón Godoy C, et al. Antimicrobial and Antibiofilm Capacity of Chitosan Nanoparticles against Wild Type Strain of Pseudomonas sp. Isolated from Milk of Cows Diagnosed with Bovine Mastitis. Antibiotics. 2020;9(9):551. doi:10.3390/antibiotics9090551
   Google Scholar
• Costa EM, Silva S, Veiga M, et al. Exploring chitosan nanoparticles as effective inhibitors of antibiotic resistant skin microorganisms - From in vitro to ex vitro testing. Carbohydr Polym. 2018;201:340–346. doi:10.1016/j.carbpol.2018.08.083
   PubMed Web of Science ®Google Scholar
• Ikono R, Vibriani A, Wibowo I, et al. Nanochitosan antimicrobial activity against Streptococcus mutans and Candida albicans dual-species biofilms. BMC Res Notes. 2019;12(1):383. doi:10.1186/s13104-019-4422-x
   PubMedGoogle Scholar
• Zhao D, Yu S, Sun B, et al. Biomedical Applications of Chitosan and Its Derivative Nanoparticles. Polymers (Basel). 2018;10(4):462. doi:10.3390/polym10040462
   PubMed Web of Science ®Google Scholar
• Nie B, et al. Bone infection site targeting nanoparticle-antibiotics delivery vehicle to enhance treatment efficacy of orthopedic implant related infection. Bioact Mater. 2022;16:134–148.
   PubMed Web of Science ®Google Scholar
• Scolari IR, Páez PL, Musri MM, et al. Rifampicin loaded in alginate/chitosan nanoparticles as a promising pulmonary carrier against Staphylococcus aureus. Drug Deliv Transl Res. 2020;10(5):1403–1417. doi:10.1007/s13346-019-00705-3
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen J, Zou L, et al. Preparation, Characterization, and Staphylococcus aureus Biofilm Elimination Effect of Baicalein-Loaded beta-Cyclodextrin-Grafted Chitosan Nanoparticles. Int J Nanomed. 2022;17:5287–5302. doi:10.2147/IJN.S383182
   PubMed Web of Science ®Google Scholar
• Zheng X, Gao M, Wu L, et al. Ceftazidime-assisted synthesis of ultrasmall chitosan nanoparticles for biofilm penetration and eradication of Pseudomonas aeruginosa. Sci Rep. 2023;13(1):13481. doi:10.1038/s41598-023-40653-0
   PubMed Web of Science ®Google Scholar
• Maya S, Indulekha S, Sukhithasri V, et al. Efficacy of tetracycline encapsulated O-carboxymethyl chitosan nanoparticles against intracellular infections of Staphylococcus aureus. Int J Biol Macromol. 2012;51(4):392–399. doi:10.1016/j.ijbiomac.2012.06.009
   PubMed Web of Science ®Google Scholar
• Jamil B, Habib H, Abbasi S, et al. Cefazolin loaded chitosan nanoparticles to cure multi drug resistant Gram-negative pathogens. Carbohydr Polym. 2016;136:682–691. doi:10.1016/j.carbpol.2015.09.078
   PubMed Web of Science ®Google Scholar
• Kovacova M, Daneu N, Tkáčiková Ľ, et al. Sustainable One-Step Solid-State Synthesis of Antibacterially Active Silver Nanoparticles Using Mechanochemistry. Nanomaterials (Basel). 2020;10(11):2119. doi:10.3390/nano10112119
   PubMedGoogle Scholar
• Bruna T, Maldonado-Bravo F, Jara P, et al. Silver Nanoparticles and Their Antibacterial Applications. Int J Mol Sci. 2021;22(13):7202. doi:10.3390/ijms22137202
   PubMed Web of Science ®Google Scholar
• Fanoro OT, Oluwafemi OS. Bactericidal Antibacterial Mechanism of Plant Synthesized Silver, Gold and Bimetallic Nanoparticles. Pharmaceutics. 2020;12(11):1044. doi:10.3390/pharmaceutics12111044
   PubMed Web of Science ®Google Scholar
• Chithambharan A, Pottail L, Mirle RM, et al. Bioinspired Gold Nanoparticle Synthesis Using Terminalia bellerica Fruit Parts and Exploring Their Anti-bacterial Potency In Vitro. Indian J Microbiol. 2021;61(3):298–305. doi:10.1007/s12088-021-00937-3
   PubMed Web of Science ®Google Scholar
• Ermini ML, Voliani V. Antimicrobial Nano-Agents: the Copper Age. ACS Nano. 2021;15(4):6008–6029. doi:10.1021/acsnano.0c10756
   PubMed Web of Science ®Google Scholar
• Yi G, Teong SP, Liu S, et al. Iron-based nano-structured surfaces with antimicrobial properties. J Mater Chem B. 2020;8(44):10146–10153. doi:10.1039/D0TB01941K
   PubMed Web of Science ®Google Scholar
• Ge J, Li M, Fan J, et al. Synthesis, characterization, and antibacterial activity of chitosan-chelated silver nanoparticles. J Biomater Sci Polym Ed. 2024;35(1):45–62. doi:10.1080/09205063.2023.2265629
   PubMed Web of Science ®Google Scholar
• Shehabeldine AM, et al. Multifunctional Silver Nanoparticles Based on Chitosan: antibacterial, Antibiofilm, Antifungal, Antioxidant, and Wound-Healing Activities. J Fungi (Basel). 2022;8(6):865.
   PubMedGoogle Scholar
• Ragab HM, et al. Fabrication and Characterization of Silver Nanoparticle-Doped Chitosan/Carboxymethyl Cellulose Nanocomposites for Optoelectronic and Biological Applications. ACS Omega. 2024;9(20):22112–22122.
   PubMed Web of Science ®Google Scholar
• Mirda E, Idroes R, Khairan K, et al. Synthesis of Chitosan-Silver Nanoparticle Composite Spheres and Their Antimicrobial Activities. Polymers (Basel). 2021;13(22):3990. doi:10.3390/polym13223990
   PubMed Web of Science ®Google Scholar
• Rezazadeh NH, Buazar F, Matroodi S. Synergistic effects of combinatorial chitosan and polyphenol biomolecules on enhanced antibacterial activity of biofunctionalaized silver nanoparticles. Sci Rep. 2020;10(1):19615. doi:10.1038/s41598-020-76726-7
   PubMed Web of Science ®Google Scholar
• Hashem AH, Shehabeldine AM, Ali OM, et al. Synthesis of Chitosan-Based Gold Nanoparticles: antimicrobial and Wound-Healing Activities. Polymers (Basel). 2022;14(11):2293. doi:10.3390/polym14112293
   PubMed Web of Science ®Google Scholar
• Fuster MG, Montalbán MG, Carissimi G, et al. Antibacterial Effect of Chitosan-Gold Nanoparticles and Computational Modeling of the Interaction between Chitosan and a Lipid Bilayer Model. Nanomaterials (Basel). 2020;10(12):2340. doi:10.3390/nano10122340
   PubMedGoogle Scholar
• Qian J, Pan C, Liang C. Antimicrobial activity of Fe-loaded chitosan nanoparticles. Eng Life Sci. 2017;17(6):629–634. doi:10.1002/elsc.201600172
   PubMed Web of Science ®Google Scholar
• Barie PS, Narayan M, Sawyer RG. Immunization Against Staphylococcus aureus Infections. Surg Infect (Larchmt). 2018;19(8):750–756. doi:10.1089/sur.2018.263
   PubMed Web of Science ®Google Scholar
• Xu C, Xing R, Liu S, et al. In vivo immunological activity of chitosan-derived nanoparticles. Int J Biol Macromol. 2024;262(Pt 2):130105. doi:10.1016/j.ijbiomac.2024.130105
   PubMedGoogle Scholar
• Hosseini SA, et al. Immunogenicity Evaluation of Recombinant Staphylococcus aureus Enterotoxin B (rSEB) and rSEB-loaded Chitosan Nanoparticles Following Nasal Administration. Iran J Allergy Asthma Immunol. 2020;19(2):159–171.
   PubMed Web of Science ®Google Scholar
• Mehrabi M, et al. Chitosan-based Nanoparticles in Mucosal Vaccine Delivery. Arch Razi Inst. 2018;73(3):165–176.
   PubMedGoogle Scholar
• Zhao J, Li J, Jiang Z, et al. Chitosan, N,N,N-trimethyl chitosan (TMC) and 2-hydroxypropyltrimethyl ammonium chloride chitosan (HTCC): the potential immune adjuvants and nano carriers. Int J Biol Macromol. 2020;154:339–348. doi:10.1016/j.ijbiomac.2020.03.065
   PubMed Web of Science ®Google Scholar
• Elifranji ZO, Haddad B, Salameh A, et al. Microbiological Profile and Drug Resistance Analysis of Postoperative Infections following Orthopedic Surgery: a 5-Year Retrospective Review. Adv Orthop. 2022;2022:7648014. doi:10.1155/2022/7648014
   PubMed Web of Science ®Google Scholar
• Runner RP, Mener A, Roberson JR, et al. Prosthetic Joint Infection Trends at a Dedicated Orthopaedics Specialty Hospital. Adv Orthop. 2019;2019:4629503. doi:10.1155/2019/4629503
   PubMed Web of Science ®Google Scholar
• Gaglio SC, et al. Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization. Vaccines (Basel). 2023;11(8).
   PubMed Web of Science ®Google Scholar
• Miyazawa N, Hakamada M, Mabuchi M. Antimicrobial mechanisms due to hyperpolarisation induced by nanoporous Au. Sci Rep. 2018;8(1):3870. doi:10.1038/s41598-018-22261-5
   PubMedGoogle Scholar
• Jedrzejczyk RJ, Turnau K, Jodłowski PJ, et al. Antimicrobial Properties of Silver Cations Substituted to Faujasite Mineral. Nanomaterials (Basel). 2017;7(9):240. doi:10.3390/nano7090240
   PubMedGoogle Scholar
• Sonin D, Pochkaeva E, Zhuravskii S, et al. Biological Safety and Biodistribution of Chitosan Nanoparticles. Nanomaterials. 2020;10(4):810. doi:10.3390/nano10040810
   Web of Science ®Google Scholar
• Rathinam S, Solodova S, Kristjánsdóttir I, et al. The antibacterial structure-activity relationship for common chitosan derivatives. Int J Biol Macromol. 2020;165(Pt B):1686–1693. doi:10.1016/j.ijbiomac.2020.09.200
   PubMedGoogle Scholar
• Xu J, et al. Antibiofilm Effect of Cinnamaldehyde-Chitosan Nanoparticles against the Biofilm of Staphylococcus aureus. Antibiotics (Basel). 2022;11(10).
   Web of Science ®Google Scholar
• Lin X, Gong X, Ruan Q, et al. Antimicrobial Application of Chitosan Derivatives and their Nanocomposites. Curr Med Chem. 2023;30(15):1736–1755. doi:10.2174/0929867329666220803114729
   PubMed Web of Science ®Google Scholar